Loading the content... Loading depends on your connection speed!

Shopping Cart - $0.00

Biologics Market Global Briefing 2017

Biologics Market Global Briefing 2017

From $1,000.00

Including: Therapeutic Proteins, Monoclonal Antibodies (MAbS), Vaccines.
Covering: Amgen, AbbVie, Johnson & Johnson, Bristol-Myers Squibb Company, Pfizer, Eli Lilly, F. Hoffmann-La Roche Ltd, Merck & Co., GlaxosmithKline, Novo Nordisk


Clear selection
SKU: 2282. Categories: , .
Description

North America was the largest region in the biologics market in 2016, accounting foraround 40% market share. This can be attributed to the high per capita healthcare expenditure in the region and the investment in novel treatments leading to the early adoption of new anti-inflammatory, anti-cancer and anti-viral biologics in the region. Western Europe was the second largest region accounting for around 22% market share. Asia Pacific was the third largest region accounting around 15% market share.

Biologics Market Global Briefing from the Business Research Company covers market characteristics, size and growth, segmentation, regional breakdowns, competitive landscape, market shares, trends and strategies for this market.

The market characteristics section of the report defines and explains the market.

The market size section gives the biologics market revenues, covering both the historic growth of the market and forecasting the future.

Drivers and restraints looks at the external factors supporting and controlling the growth of the market.

Market segmentations break down the key sub sectors which make up the market. The regional breakdowns section gives the size of the market geographically.

Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in the last three years are identified.

The trends and strategies section highlights the likely future developments in the biologics market and suggests approaches.

Reasons to Purchase

• Get up to date information available on the biologics market globally.
• Identify growth segments and opportunities.
• Facilitate decision making on the basis of historic and forecast data and understand the drivers and restraints on the market.
• Develop strategies based on likely future developments.
• Gain a global perspective on the development of the market.

Scope

Markets Covered: Therapeutic Proteins, Monoclonal Antibodies (MAbS), Vaccines.
Companies Mentioned: Amgen, AbbVie, Johnson & Johnson, Bristol-Myers Squibb Company, Pfizer, Eli Lilly, F. Hoffmann-La Roche Ltd, Merck & Co., GlaxosmithKline, Novo Nordisk
Geographic scope: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Africa
Time series: Five years historic and forecast.
Data: Market value in $ billions.
Data segmentations: Regional breakdowns, market share of competitors, key sub segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

 

Executive Summary
The biologics industry comprises companies manufacturing biological products that are derived from genetically modified proteins and human genes. Biologics products include a wide range of recombinant therapeutic proteins, gene therapy tissues, somatic cells, vaccines, and allergenics. These products are isolated from natural sources such as human, animal, and microorganisms by biotechnological methods and other cutting-edge technologies.

The global biologics market is expected to reach around $291 billion in 2020. This can be attributed to the increasing evidence of positive responses to treatment with biologics, availability of advanced diagnostics increasing the treatment population, and rising government initiatives for the research and development of biologics globally thereby increasing the acceptance of the products in the market and increasing amount of patient population using the biologics. 

Demand For Biologics In The Treatment Of Complex Diseases - Biologics are being widely used to provide effective treatment for many complex diseases such as rheumatoid arthritis, psoriasis, Crohn’s disease that have limited treatment options. There has been a significant advancement for the treatment of Rheumatoid arthritis patients who do not respond to traditional disease-modifying anti-rheumatic drugs. The key biologics used for the treatment of Rheumatoid arthritis include Abatacept (Orencia), Adalimumab (Humira), Anakinra (Kineret), Infliximab (Remicade), and Rituximab (Rituxan). Key biologics used to treat psoriasis include Adalimumab (Humira), Etanercept (Enbrel), Infliximab (Remicade), Secukinumab ( Cosentyx). Cimzia (certolizumab pegol), Humira (adalimumab), and Remicade (infliximab), Tysabri (natalizumab) are biologics that are used to treat Crohn’s disease.
Table of Contents
Biologics Market Characteristics 5
Biologics Market Historic Growth 7
Biologics Market Forecast Growth 8
Biologics Market Segmentation 9
Global Biologics Market, Split By Segments, 2016, $ Billion 9
Therapeutic Proteins 9
Monoclonal Antibodies (MAbS) 10
Vaccines 10
Global Biologics Market, Historic and Forecast, Split By Segments, 2012-2020 11
Biologics Market Geography Regional and Country Comparison 13
Global Biologics Market, Split By Regions, 2016 13
Global Biologics Market, Historic And Forecast Growth Rate, Split By Region, 2012-2020 15
Global Biologics Market, Split By Country, 2016 17
Global Biologics Market, Historic And Forecast Growth Rate, Split By Country, 2012-2020 19
Biologics Market Competitive Landscape 21
Amgen Inc. 22
AbbVie Inc. 22
Johnson & Johnson 22
Bristol-Myers Squibb Company 22
Pfizer Inc. 22
Merck & Co. 22
F. Hoffmann-La Roche Ltd. 22
Eli Lilly And Company 22
GlaxosmithKline Plc. 22
Sanofi S.A. 22
Amgen 23
AbbVie 23
Johnson & Johnson (J&J) 24
Biologics Market Key Mergers And Acquisitions 25
ADMA Biologics Acquired Biotest’s Therapy Business 25
Pfizer Acquired Baxter’s Vaccine Portfolio 25
GlaxoSmithKline Acquired Okairos AG 25
CSL Acquired Novartis’ Vaccine Business 25
Serum Institute Acquired Nanotherapeutics Inc. 25
Eagle Pharmaceuticals Acquired Arsia Therapeutics 26
Takeda Acquired Baxalta’s Manufacturing Facility 26
Biologics Market Trends And Strategies 27
Demand For Biologics In The Treatment Of Complex Diseases 27
Increasing Demand For Antibody Drug Conjugates (ADCs) 27
Development Of Next Generation Biologics 27
Revised FDA Approvals To Facilitate Biologics Drug Development 28
Appendix 29
NAICS Definitions Of Industry Covered In This Report 29
Definition Of Market Covered In This Report 29
Abbreviations 29
Currencies 29
Research Methodology 29
Research Inquiries 30
The Business Research Company 30

List of Figures
Figure 1: Global Biologics Market, Historic Market Size, 2012-2016, $ Billion 7
Figure 2: Global Biologics Market, Forecast Market Size, 2016 – 2020, $ Billion 8
Figure 3: Global Biologics Market, Split By Segments, 2016, $ Billion 9
Figure 4: Global Biologics Market, Historic and Forecast, Split By Segment, 2012 – 2020 11
Figure 5: Global Biologics Market, Split By Region, 2016, $ Billion 13
Figure 6: Global Biologics Market, Historic And Forecast Growth Rate, Split By Region, 2012-2020 15
Figure 7: Global Biologics Market, Split By Country, 2016, $ Billion 17
Figure 8: Global Biologics Market, Historic And Forecast Growth Rate, Split By Country, 2012-2020 19
Figure 9: Global Biologics Market, Key Competitor Market Shares, 2016, Percentage (%) 21

List of Tables
Table 1: Global Biologics Market, Historic Market Size, 2012-2016, $ Billion 7
Table 2: Global Biologics Market, Forecast Market Size, 2016 – 2020, $ Billion 8
Table 3: Global Biologics Market, Split By Segments, 2016, $ Billion 9
Table 4: Global Biologics Market, Historic and Forecast, Split By Segment, 2012 – 2020 11
Table 5: Global Biologics Market, Split By Region, 2016, $ Billion 14
Table 6: Global Biologics Market, Historic And Forecast Growth Rate, Split By Region, 2012-2020 15
Table 7: Global Biologics Market, Split By Country, 2016, $ Billion 17
Table 8: Global Biologics Market, Historic And Forecast Growth Rate, Split By Country, 2012-2020 19
Table 9: Global Biologics Market, Key Competitor Market Shares, 2016, Percentage (%) 22
Get Customized Report
Please fill in your details. Our team will get back to you